Clinical implications of mutational analysis in gastrointestinal stromal tumours
Open Access
- 5 February 2008
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (4) , 684-688
- https://doi.org/10.1038/sj.bjc.6604217
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mutations in gastrointestinal stromal tumors – a population‐based study from Northern NorwayAPMIS, 2007
- Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib SensitivityGastroenterology, 2006
- Gastrointestinal stromal tumor (GIST)Annals of Oncology, 2006
- Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor PrognosisGastroenterology, 2006
- KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursEuropean Journal Of Cancer, 2006
- PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to ImatinibJournal of Clinical Oncology, 2005
- Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate eraCancer, 2005
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Prognostic Value ofKITMutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal TumorsJournal of Clinical Oncology, 2002
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998